Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
xtandi tablet - Google News
Get the latest updates from xtandi tablet - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 2 years ago
Merck Stops Trial of Pembrolizumab Plus Olaparib in Metastatic Castration-Resistant Prostate Cancer - Pharmacy Times
about 2 years ago
Merck Stops Trial of Pembrolizumab Plus Olaparib in Metastatic Castration-Resistant Prostate Cancer...
Best Practices Using SSR Health Net Drug Pricing Data - healthaffairs.org
about 2 years ago
Best Practices Using SSR Health Net Drug Pricing Data healthaffairs.org
Best Practices Using SSR Health Net Drug Pricing Data - healthaffairs.org
about 2 years ago
Best Practices Using SSR Health Net Drug Pricing Data healthaffairs.org
Worried About Computer Software Assurance? Relax, You're Probably Already Doing It - FiercePharma
about 2 years ago
Worried About Computer Software Assurance? Relax, You're Probably Already Doing It FiercePharma
Billionaire Sackler family enters $6B opioid deal with support from holdout states - FiercePharma
about 2 years ago
Billionaire Sackler family enters $6B opioid deal with support from holdout states...
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its merits - FiercePharma
about 2 years ago
Amgen, NHS strike deal to expand Lumykras access in UK as watchdog...
FDA says no, thank you to Xpovio's cancer expansion bid, prompting Karyopharm to run new study - FiercePharma
about 2 years ago
FDA says no, thank you to Xpovio's cancer expansion bid, prompting Karyopharm...
Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on - FiercePharma
about 2 years ago
Novartis sells pair of manufacturing plants as Sandoz strategic review rolls on...
Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates - FiercePharma
about 2 years ago
Sanofi's net prices keep slipping—despite list price hikes—thanks to billions in rebates...
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big sales on the line - FiercePharma
about 2 years ago
BMS, Novartis, Akebia and more face FDA approval decisions soon, with big...
Pfizer, following last year's Chantix recall, pulls blood pressure med in Canada on carcinogen fears - FiercePharma
about 2 years ago
Pfizer, following last year's Chantix recall, pulls blood pressure med in Canada...
A year later at the SOTU, deja vu all over again as Biden calls for lower drug prices, zeroing in on insulin - FiercePharma
about 2 years ago
A year later at the SOTU, deja vu all over again as...